期刊文献+

一组细胞角蛋白抗体在胸腹腔积液中的表达及其鉴别诊断价值

A Panel of Cytokeratin Antibodies Expression and its Value of Differential Diagnosis in Pleural and Peritoneal Effusion
下载PDF
导出
摘要 目的:探讨一组细胞角蛋白抗体在胸腹腔积液中的表达情况及其临床应用价值。方法:选取72例胸腹腔积液标本,其中腺癌30例,鳞癌22例,反应增生性间皮细胞22例,应用细胞免疫化学SP法检测细胞角蛋白CK(AE1/AE3)、细胞角蛋白5/6(CK5/6)、细胞角蛋白18(CK18)的表达。结果:三种抗体在反应增生性间皮细胞、腺癌细胞、鳞癌细胞中阳性率分别是CK(AE1/AK3):10.0%,73.3%,68.2%;CK5/6:60.0%,6.7%,77.3%;CK18:0,80.0%,4.5%。组合CK(AE1/AE3)(-)、CK5/6(+)、CK18(-)检测间皮细胞的敏感性为93.3%,特异性为80.2%;CK5/6(-)、CK18(+)检测腺癌细胞的敏感性为84.7%,特异性为93.6%;CK(AE1/AE3)(+)、CK5/6(+)、CK18(一)检测鳞癌细胞的敏感性为86.4%,特异性为92.8%。结论:多项细胞角蛋白联检提高了诊断反应增生性间皮细胞、腺癌细胞、鳞癌细胞的敏感性和特异性,可辅助细胞形态学对于良恶性胸腹腔积液的鉴别诊断。 Objective To study the expressive and applicative value of a panel of cytokeratin antibodies in pleural and peritoneal effusion. Methods SP immunocytoehemisitry technique was used to detect the expression of CK, CK5/6, CKI8 in seventy-two cases pleural and peritoneal effusion samples ,30 cases of adenocarcinoma ,22 cases of squamous carcinoma and 20 cases of reactive proliferation mesothelial cells. Results Expression positivity rates of three antibodies in mesothelial, adeno and squamous carcinoma cells were CK ( AE/AE3 ) : 10.0% ,73.3 %, 68.2% ; CK5/6 : 60.0%, 6.7 % ,77.3 % ; CK18 : 0,80.0% ,4.5 % respectively , CK ( AE1/ AE3) ( - ) ;CK5/6( + ) ,CK18( - ) identified mesothelial cell with 93.3% sensitivity and 80.2% specificity ; CK5/6( - ), CK18 ( + )identified adenocarcinoma cell with 84.7% sensitivity and 93.6% specificity; CK (AE1/AE3) ( + ), CK5/6 ( + ), CK18 ( - ) identified squamous cell carcinomas with 86.4% sensitivity and 92.8% specificity. Conclusion The eoexpression of muhinomial eytokeratin improve the sensitivity and speciality of mesothelial, adeno and squamous carcinoma cells , and assist cytomorphology in differential diagnosis between benign and pleural and malignant peritoneal effusion .
出处 《放射免疫学杂志》 CAS 2012年第1期60-63,共4页 Journal of Radioimmanology
关键词 细胞角蛋白 胸腹腔积液 细胞免疫化学 间皮细胞 腺癌 鳞癌 cytokeratin, pleural and peritoneal effusion, immunocytochemisitry, mesothelial cell, adenoeareinoma, squamous carcinomas
  • 相关文献

参考文献9

  • 1Festch PA,Abati A.Immunocytochemistry in effusion cytology,a contemporary review[J].Cancer,2001,93(5):293-308.
  • 2Fesch PA,Simsir A,Brosky K,et al.Comparison of three commonly used cytologic preparations in effusion immunocytochemistiy[J].Diag Cytopathol,2002,26(1):61 -63.
  • 3Wu Gp,Zhang SS,Fang CQ,et al.Immunocytochemical panel for distinguishing carcinoma cells from reactive mesothelial cells in pleural effusions[J].Cytopathol,2008,19(4):212-217.
  • 4Amin MB,Tamboli P,Merchant SH,et al.Micropapillary component in lung adenocarcinoma:a distinctive histologic feature with possible prognostic significance[J].Am J Surg Pathol,2002,26(3):358-364.
  • 5Kakehashi A,Kuto A,Inoue M,et al.Cytokeratin 8/18 as a new marker of mouse liver preneoplastic lesions[J] ,Tozicol Appl Pharmacol,2010,242(1);47-55.
  • 6丁华新,何向蕾,陈培辉.免疫细胞化学在胸腹水细胞学鉴别诊断中的应用[J].诊断病理学杂志,2002,9(4):220-221. 被引量:5
  • 7邬万新,张燕萍,温晓伟,陆宁,唐正英.细胞角蛋白亚型和TTF-1判断癌性体腔积液原发灶的价值[J].中国肿瘤临床,2006,33(14):788-791. 被引量:3
  • 8Chu PG,Weiss LM.Expression of cytokeratin 5/6 in epithelial neoplasms:an immunohistochemical study of 509 cases[J].Mod Pathol,2002,15(1):6-10.
  • 9Zimmerman RL.Effusion cytology:Keeping researchers and journals in business for the past 20 years and it is not over yet[J].Curr Diag Pathol,2005,11(6):194-202.

二级参考文献13

  • 1Mohanty SK,Dey P.Serous effusions:diagnosis of malignancy beyond cytomorphology.An analytic review[J].Postgrad Med J,2003,79(936):569~574
  • 2Zimmerman RL.Effusion cytology:Keeping researchers and journals in business for the past 20 years and it is not over yet[J].Curr Diag Pathol,2005,11(6):194~ 202
  • 3Chu PG,Weiss LM.Keratin expression in human tissues and neoplasms[J].Histopathology,2002,40(5):403~439
  • 4Johansson L.Histopathologic classification of lung cancer:Relevance of cytokeratin and TTF-1 immunophenotyping[J].Ann Diagn Pathol,2004,8(5):259~267
  • 5Fetsch PA,Abati A.Immunocytochemistry in effusion cytology:a contemporary review[J].Cancer,2001,93(5):293~308
  • 6Tot T.Cytokeratins 20 and 7 as biomarkers:usefulness in discriminating primary from metastatic adenocarcinoma[J].Eur J Cancer,2002,38(6):758~763
  • 7Park SY,Kim HS,Hong EK,et al.Expression of cytokeratins 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas to the ovary[J].Hum Pathol,2002,33(11):1078~1085
  • 8Drlicek M,Bodenteich A,Urbanits S,et al.Immunohistochemical panel of antibodies in the diagnosis of brain metastases of the unknown primary[J].Pathol Res Prac,2004,200(10):727~734
  • 9Fernandez CG,Jorda M,Delgado PI,et al.Thyroid transcription factor 1,a marker for lung adenocarcinoma in body cavity fluids[J].Cancer Cytopathol,2002 96(5):289~ 293
  • 10Jerome MV,Mazieres J,Groussard O,et al.Expression of TTF-1 and cytokeratins in primary and secondary epithelial lung tumours:correlation with histological type and grade[J].Histopathology,2004,45(2):125~ 134

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部